{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:52:12Z","timestamp":1781236332255,"version":"3.54.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"6801","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1038\/35025215","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:45:49Z","timestamp":1027673149000},"page":"242-248","source":"Crossref","is-referenced-by-count":2929,"title":["Vascular-specific growth factors and blood vessel formation"],"prefix":"10.1038","volume":"407","author":[{"given":"George D.","family":"Yancopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas W.","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Rudge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley J.","family":"Wiegand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Holash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF35025215_CR1","first-page":"1","volume":"237","author":"N Ferrara","year":"1999","unstructured":"Ferrara, N. Vascular endothelial growth factor: molecular and biological aspects. Curr. Top. Microbiol. Immunol. 237, 1\u2013 30 (1999).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BF35025215_CR2","first-page":"97","volume":"237","author":"HF Dvorak","year":"1999","unstructured":"Dvorak, H. F., Nagy, J. A., Feng, D., Brown, L. F. & Dvorak, A. M. Vascular permeability factor\/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis . Curr. Top. Microbiol. Immunol. 237, 97 \u2013132 (1999).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BF35025215_CR3","first-page":"41","volume":"237","author":"U Eriksson","year":"1999","unstructured":"Eriksson, U. & Alitalo, K. Structure, expression and receptor-binding properties of novel vascular endothelial growth factors. Curr. Top. Microbiol. Immunol. 237, 41\u201357 (1999).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BF35025215_CR4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/386671a0","volume":"386","author":"W Risau","year":"1997","unstructured":"Risau, W. Mechanisms of angiogenesis. Nature 386, 671\u2013674 (1997).","journal-title":"Nature"},{"key":"BF35025215_CR5","first-page":"1625","volume":"37","author":"BM Kenyon","year":"1996","unstructured":"Kenyon, B. M. et al. A model of angiogenesis in the mouse cornea. Invest. Ophthalmol. Vis. Sci. 37, 1625\u20131632 (1996).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BF35025215_CR6","first-page":"1189","volume":"40","author":"D Ribatti","year":"1996","unstructured":"Ribatti, D., Vacca, A., Roncali, L. & Dammacco, F. The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis. Int. J. Dev. Biol. 40, 1189\u20131197 (1996).","journal-title":"Int. J. Dev. Biol."},{"key":"BF35025215_CR7","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1101\/gad.13.9.1055","volume":"13","author":"NW Gale","year":"1999","unstructured":"Gale, N. W. & Yancopoulos, G. D. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 13, 1055\u20131066 (1999).","journal-title":"Genes Dev."},{"key":"BF35025215_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/74651","volume":"6","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet, P. Mechanisms of angiogenesis and arteriogenesis. Nature Med. 6, 389\u2013395 (2000).","journal-title":"Nature Med."},{"key":"BF35025215_CR9","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1242\/dev.126.14.3047","volume":"126","author":"M Hellstrom","year":"1999","unstructured":"Hellstrom, M., Kaln, M., Lindahl, P., Abramsson, A. & Betsholtz, C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126, 3047\u2013 3055 (1999).","journal-title":"Development"},{"key":"BF35025215_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1161\/01.RES.84.3.298","volume":"84","author":"KK Hirschi","year":"1999","unstructured":"Hirschi, K. K., Rohovsky, S. A., Beck, L. H., Smith, S. R. & D'Amore, P. A. Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ. Res. 84, 298\u2013305 (1999).","journal-title":"Circ. Res."},{"key":"BF35025215_CR11","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0092-8674(00)81813-9","volume":"87","author":"C Suri","year":"1996","unstructured":"Suri, C. et al. Requisite role of Angiopoietin-1, a ligand for the Tie2 receptor, during embryonic angiogenesis. Cell 87, 1171\u20131180 (1996).","journal-title":"Cell"},{"key":"BF35025215_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/science.277.5322.55","volume":"277","author":"PC Maisonpierre","year":"1997","unstructured":"Maisonpierre, P. C. et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55\u2013 60 (1997).","journal-title":"Science"},{"key":"BF35025215_CR13","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1038\/sj.onc.1203035","volume":"18","author":"J Holash","year":"1999","unstructured":"Holash, J., Wiegand, S. J. & Yancopoulos, G. D. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18, 5356\u20135362 ( 1999).","journal-title":"Oncogene"},{"key":"BF35025215_CR14","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1126\/science.284.5422.1994","volume":"284","author":"J Holash","year":"1999","unstructured":"Holash, J. et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284, 1994\u20131998 (1999).","journal-title":"Science"},{"key":"BF35025215_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0092-8674(00)81402-6","volume":"92","author":"S Soker","year":"1998","unstructured":"Soker, S., Takashima, S., Miao, H., Neufeld, G. & Klagsbrun, M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735\u2013745 ( 1998).","journal-title":"Cell"},{"key":"BF35025215_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/376062a0","volume":"376","author":"F Shalaby","year":"1995","unstructured":"Shalaby, F. et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62\u201366 (1995).","journal-title":"Nature"},{"key":"BF35025215_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/376066a0","volume":"376","author":"GH Fong","year":"1995","unstructured":"Fong, G. H., Rossant, J., Gertenstein, M. & Breitman, M. L. Role of the Flt-1 receptor tyrosine kinase in regulating assembly of vascular endothelium. Nature 376, 66\u2013 70 (1995).","journal-title":"Nature"},{"key":"BF35025215_CR18","doi-asserted-by":"publisher","first-page":"9349","DOI":"10.1073\/pnas.95.16.9349","volume":"95","author":"S Hiratsuka","year":"1998","unstructured":"Hiratsuka, S., Minowa, O., Kuno, J., Noda, T. & Shibuya, M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl Acad. Sci. USA 95, 9349\u20139354 ( 1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF35025215_CR19","first-page":"85","volume":"237","author":"J Taipale","year":"1999","unstructured":"Taipale, J. et al. Vascular endothelial growth factor receptor-3. Curr. Top. Microbiol. Immunol. 237, 85\u2013 96 (1999).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BF35025215_CR20","first-page":"31","volume":"237","author":"MG Persico","year":"1999","unstructured":"Persico, M. G., Vincenti, V. & DiPalma, T. Structure, expression and receptor-binding properties of placenta growth factor (PlGF). Curr. Top. Microbiol. Immunol. 237, 31\u201340 ( 1999).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BF35025215_CR21","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S0958-1669(99)00024-5","volume":"10","author":"B Olofsson","year":"1999","unstructured":"Olofsson, B., Jeltsch, M., Eriksson, U. & Alitalo, K. Current biology of VEGF-B and VEGF-C. Curr. Opin. Biotechnol. 10, 528\u2013535 (1999).","journal-title":"Curr. Opin. Biotechnol."},{"key":"BF35025215_CR22","doi-asserted-by":"publisher","first-page":"E29","DOI":"10.1161\/01.RES.86.2.e29","volume":"86","author":"D Bellomo","year":"2000","unstructured":"Bellomo, D. et al. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ. Res. 86, E29\u2013E35 (2000).","journal-title":"Circ. Res."},{"key":"BF35025215_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/380435a0","volume":"380","author":"P Carmeliet","year":"1996","unstructured":"Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435\u2013439 (1996).","journal-title":"Nature"},{"key":"BF35025215_CR24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/380439a0","volume":"380","author":"N Ferrara","year":"1996","unstructured":"Ferrara, N. et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439\u2013 442 (1996).","journal-title":"Nature"},{"key":"BF35025215_CR25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/8379","volume":"5","author":"P Carmeliet","year":"1999","unstructured":"Carmeliet, P. et al. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nature Med. 5, 495\u2013 502 (1999).","journal-title":"Nature Med."},{"key":"BF35025215_CR26","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1242\/dev.127.18.3941","volume":"127","author":"L Miquerol","year":"2000","unstructured":"Miquerol, L., Langille, B. L. & Nagy, A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 127, 3941\u20133946 ( 2000).","journal-title":"Development"},{"key":"BF35025215_CR27","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1242\/dev.126.6.1149","volume":"126","author":"HP Gerber","year":"1999","unstructured":"Gerber, H. P. et al. VEGF is required for growth and survival in neonatal mice . Development 126, 1149\u2013 1159 (1999).","journal-title":"Development"},{"key":"BF35025215_CR28","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nm0398-336","volume":"4","author":"N Ferrara","year":"1998","unstructured":"Ferrara, N. et al. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nature Med. 4, 336\u2013 340 (1998).","journal-title":"Nature Med."},{"key":"BF35025215_CR29","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/9467","volume":"5","author":"HP Gerber","year":"1999","unstructured":"Gerber, H. P. et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nature Med. 5, 623\u2013628 ( 1999).","journal-title":"Nature Med."},{"key":"BF35025215_CR30","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995","volume":"15","author":"J Stone","year":"1995","unstructured":"Stone, J. et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neurosci. 15, 4738\u20134747 (1995).","journal-title":"J. Neurosci."},{"key":"BF35025215_CR31","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/nm1095-1024","volume":"1","author":"T Alon","year":"1995","unstructured":"Alon, T. et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity . Nature Med. 1, 1024\u20131028 (1995).","journal-title":"Nature Med."},{"key":"BF35025215_CR32","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1242\/dev.125.9.1591","volume":"125","author":"LE Benjamin","year":"1998","unstructured":"Benjamin, L. E., Hemo, I. & Keshet, E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125, 1591 \u20131598 (1998).","journal-title":"Development"},{"key":"BF35025215_CR33","first-page":"290","volume":"37","author":"J Stone","year":"1996","unstructured":"Stone, J. et al. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 37, 290\u2013299 ( 1996).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BF35025215_CR34","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1001\/archopht.1996.01100140419009","volume":"114","author":"EA Pierce","year":"1996","unstructured":"Pierce, E. A., Foley, E. D. & Smith, L. E. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch. Ophthalmol . 114, 1219\u20131228 ( 1996). [Published erratum appears in Arch. Ophthalmol. 115, 427 (1997).]","journal-title":"Arch. Ophthalmol"},{"key":"BF35025215_CR35","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","volume":"331","author":"LP Aiello","year":"1994","unstructured":"Aiello, L. P. et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331, 1480\u20131487 ( 1994).","journal-title":"N. Engl. J. Med."},{"key":"BF35025215_CR36","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0002-9394(14)75794-0","volume":"118","author":"AP Adamis","year":"1994","unstructured":"Adamis, A. P. et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Ophthalmol. 118, 445\u2013450 (1994).","journal-title":"Am. J. Ophthalmol."},{"key":"BF35025215_CR37","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1097-2765(00)80154-9","volume":"2","author":"ML Springer","year":"1998","unstructured":"Springer, M. L., Chen, A. S., Kraft, P. E., Bednarski, M. & Blau, H. M. VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol. Cell 2, 549\u2013558 (1998).","journal-title":"Mol. Cell"},{"key":"BF35025215_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1523-1747.1998.00262.x","volume":"111","author":"M Detmar","year":"1998","unstructured":"Detmar, M. et al. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J. Invest. Dermatol. 111, 1\u20136 (1998 ).","journal-title":"J. Invest. Dermatol."},{"key":"BF35025215_CR39","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/sj.onc.1201928","volume":"17","author":"F Larcher","year":"1998","unstructured":"Larcher, F., Murillas, R., Bolontrade, M., Conti, C. J. & Jorcano, J. L. VEGF\/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene 17, 303\u2013 311 (1998).","journal-title":"Oncogene"},{"key":"BF35025215_CR40","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1126\/science.286.5449.2511","volume":"286","author":"G Thurston","year":"1999","unstructured":"Thurston, G. et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286, 2511\u2013 2514 (1999).","journal-title":"Science"},{"key":"BF35025215_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/labinvest.3780013","volume":"80","author":"A Pettersson","year":"2000","unstructured":"Pettersson, A. et al. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor\/vascular endothelial growth factor. Lab. Invest. 80, 99\u2013 115 (2000).","journal-title":"Lab. Invest."},{"key":"BF35025215_CR42","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/74725","volume":"6","author":"G Thurston","year":"2000","unstructured":"Thurston, G. et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nature Med. 6, 460\u2013 463 (2000).","journal-title":"Nature Med."},{"key":"BF35025215_CR43","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1182\/blood.V80.10.2548.2548","volume":"80","author":"J Korhonen","year":"1992","unstructured":"Korhonen, J. et al. Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood 80, 2548\u20132555 (1992).","journal-title":"Blood"},{"key":"BF35025215_CR44","first-page":"1631","volume":"8","author":"PC Maisonpierre","year":"1993","unstructured":"Maisonpierre, P. C., Goldfarb, M., Yancopoulos, G. D. & Gao, G. Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family. Oncogene 8, 1631 \u20131637. (1993).","journal-title":"Oncogene"},{"key":"BF35025215_CR45","doi-asserted-by":"publisher","first-page":"9355","DOI":"10.1073\/pnas.90.20.9355","volume":"90","author":"TN Sato","year":"1993","unstructured":"Sato, T. N., Qin, Y., Kozak, C. A. & Audus, K. L. tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc. Natl Acad. Sci. USA 90, 9355\u20139358 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF35025215_CR46","first-page":"1293","volume":"8","author":"DJ Dumont","year":"1993","unstructured":"Dumont, D. J., Gradwohl, G. J., Fong, G.-H., Auerbach, R. & Breitman, M. L. The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors. Oncogene 8, 1293\u20131301 ( 1993).","journal-title":"Oncogene"},{"key":"BF35025215_CR47","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1006\/bbrc.1993.2045","volume":"195","author":"A Iwama","year":"1993","unstructured":"Iwama, A. et al. Molecular cloning and characterization of mouse Tie and Tek receptor tyrosine kinase genes and their expression in hematopoietic stem cells. Biochem. Biophys. Res. Commun. 195, 301\u2013309 (1993).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BF35025215_CR48","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S0092-8674(00)81812-7","volume":"87","author":"S Davis","year":"1996","unstructured":"Davis, S. et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87, 1161\u20131169 (1996).","journal-title":"Cell"},{"key":"BF35025215_CR49","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1073\/pnas.96.5.1904","volume":"96","author":"D Valenzuela","year":"1999","unstructured":"Valenzuela, D. et al. Angiopoietins 3 and 4: diverging gene counterparts in mouse and man. Proc. Natl Acad. Sci. USA 96, 1904 \u20131909 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF35025215_CR50","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1101\/gad.8.16.1897","volume":"8","author":"DJ Dumont","year":"1994","unstructured":"Dumont, D. J. et al. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8, 1897\u2013 1909 (1994).","journal-title":"Genes Dev."},{"key":"BF35025215_CR51","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/376070a0","volume":"376","author":"TN Sato","year":"1995","unstructured":"Sato, T. N. et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376, 70\u201374 (1995).","journal-title":"Nature"},{"key":"BF35025215_CR52","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.282.5388.468","volume":"282","author":"C Suri","year":"1998","unstructured":"Suri, C. et al. Angiopoietin-1 promotes increased vascularization in vivo. Science 282, 468\u2013471 ( 1998).","journal-title":"Science"},{"key":"BF35025215_CR53","first-page":"1385","volume":"78","author":"V Goede","year":"1998","unstructured":"Goede, V., Schmidt, T., Kimmina, S., Kozian, D. & Augustin, H. G. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab. Invest. 78, 1385\u20131394 (1998).","journal-title":"Lab. Invest."},{"key":"BF35025215_CR54","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0002-9440(10)65733-1","volume":"153","author":"A Stratmann","year":"1998","unstructured":"Stratmann, A., Risau, W. & Plate, K. H. Cell type-specific expression of Angiopoietin-1 and Angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am. J. Pathol. 153, 1459\u20131466 (1998).","journal-title":"Am. J. Pathol."},{"key":"BF35025215_CR55","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1006\/exnr.1999.7162","volume":"159","author":"D Zagzag","year":"1999","unstructured":"Zagzag, D. et al. In Situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis. Exp. Neurol. 159, 391\u2013400 ( 1999).","journal-title":"Exp. Neurol."},{"key":"BF35025215_CR56","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev.neuro.21.1.309","volume":"21","author":"JG Flanagan","year":"1998","unstructured":"Flanagan, J. G. & Vanderhaeghen, P. The ephrins and Eph receptors in neural development. Annu. Rev. Neurosci. 21, 309\u2013345 (1998).","journal-title":"Annu. Rev. Neurosci."},{"key":"BF35025215_CR57","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.7973638","volume":"266","author":"S Davis","year":"1994","unstructured":"Davis, S. et al. Ligands for the EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science 266, 816\u2013819 (1994).","journal-title":"Science"},{"key":"BF35025215_CR58","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0092-8674(00)81436-1","volume":"93","author":"HU Wang","year":"1998","unstructured":"Wang, H. U., Chen, Z. & Anderson, D. J. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93, 741\u2013753 (1998).","journal-title":"Cell"},{"key":"BF35025215_CR59","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1101\/gad.13.3.295","volume":"13","author":"RH Adams","year":"1999","unstructured":"Adams, R. H. et al. Roles for ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial\/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 13, 295\u2013306 (1999).","journal-title":"Genes Dev."},{"key":"BF35025215_CR60","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S1097-2765(00)80342-1","volume":"4","author":"SS Gerety","year":"1999","unstructured":"Gerety, S. S., Wang, H. U., Chen, Z. F. & Anderson, D. J. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol. Cell 4, 403\u2013414 (1999).","journal-title":"Mol. Cell"},{"key":"BF35025215_CR61","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM197108122850711","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182\u20131186 ( 1971).","journal-title":"N. Engl. J. Med."},{"key":"BF35025215_CR62","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/jnci\/82.1.4","volume":"82","author":"J Folkman","year":"1990","unstructured":"Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Instit. 82, 4\u20136 (1990).","journal-title":"J. Natl. Cancer Instit."},{"key":"BF35025215_CR63","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","volume":"86","author":"D Hanahan","year":"1996","unstructured":"Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353\u2013364 (1996).","journal-title":"Cell"},{"key":"BF35025215_CR64","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3171\/jns.1994.81.6.0902","volume":"81","author":"P Wesseling","year":"1994","unstructured":"Wesseling, P., van der Laak, J. A., de Leeuw, H., Ruiter, D. J. & Burger, P. C. Quantitative immunohistological analysis of the microvasculature in untreated human glioblastome multiforme . J Neurosurg. 81, 902\u2013 909 (1994).","journal-title":"J Neurosurg."},{"key":"BF35025215_CR65","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nm0295-149","volume":"1","author":"L Holmgren","year":"1995","unstructured":"Holmgren, L., O'Reilly, M. S. & Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med. 1, 149\u2013153 ( 1995).","journal-title":"Nature Med."},{"key":"BF35025215_CR66","first-page":"1417","volume":"151","author":"F Pezzella","year":"1997","unstructured":"Pezzella, F. et al. Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am. J. Pathol. 151, 1417\u20131423 (1997).","journal-title":"Am. J. Pathol."},{"key":"BF35025215_CR67","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/362841a0","volume":"362","author":"KJ Kim","year":"1993","unstructured":"Kim, K. J. et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841\u2013844 (1993).","journal-title":"Nature"},{"key":"BF35025215_CR68","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/70928","volume":"5","author":"N Ferrara","year":"1999","unstructured":"Ferrara, N. & Alitalo, K. Clinical applications of angiogenic growth factors and their inhibitors. Nature Med. 5, 1359\u20131364 (1999).","journal-title":"Nature Med."},{"key":"BF35025215_CR69","doi-asserted-by":"publisher","first-page":"65A","DOI":"10.1016\/S0735-1097(97)83989-7","volume":"31","author":"TD Henry","year":"1998","unstructured":"Henry, T. D. et al. Results of intracoronary recombinant human vascular endothelial growth factor (RhVEGF) administration trial. J. Am. Coll. Cardiol. 31, 65A (1998).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BF35025215_CR70","unstructured":"Chiron Coorporation. Chiron announces preliminary findings from phase II clinical trial of FGF-2. \u3008 http:\/\/www.prnewswire.com\/micro\/CHIR \u3009 Company Press Release 12 March 2000."},{"key":"BF35025215_CR71","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","volume":"79","author":"MS O'Reilly","year":"1994","unstructured":"O'Reilly, M. S. et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis Lung Carcinoma. Cell 79, 315\u2013328 (1994).","journal-title":"Cell"},{"key":"BF35025215_CR72","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","volume":"88","author":"MS O'Reilly","year":"1997","unstructured":"O'Reilly, M. S. et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277\u2013285 (1997).","journal-title":"Cell"},{"key":"BF35025215_CR73","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1126\/science.285.5435.1926","volume":"285","author":"MS O'Reilly","year":"1999","unstructured":"O'Reilly, M. S., Pirie-Shepherd, S., Lane, W. S. & Folkman, J. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin . Science 285, 1926\u20131928 (1999).","journal-title":"Science"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/35025215.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/35025215","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/35025215.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T02:07:02Z","timestamp":1684289222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/35025215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":73,"journal-issue":{"issue":"6801","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["BF35025215"],"URL":"https:\/\/doi.org\/10.1038\/35025215","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}